Botanix Pharmaceuticals Limited
BXPHF
$0.099
-$0.001-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.60M | -40.59M | -25.94M | -17.66M | -9.10M |
| Total Depreciation and Amortization | 1.47M | 1.12M | 781.10K | 419.50K | 47.70K |
| Total Amortization of Deferred Charges | 3.24M | 1.60M | -- | -- | -- |
| Total Other Non-Cash Items | 13.03M | 7.07M | 1.25M | 2.06M | 2.88M |
| Change in Net Operating Assets | -12.77M | -5.90M | 840.50K | 840.50K | 840.50K |
| Cash from Operations | -50.64M | -36.70M | -23.07M | -14.34M | -5.33M |
| Capital Expenditure | -183.90K | -146.40K | -110.20K | -92.50K | -74.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -504.50K | -1.54M | -2.58M | -7.13M | -11.70M |
| Cash from Investing | -688.40K | -1.69M | -2.69M | -7.22M | -11.77M |
| Total Debt Issued | 28.40M | 14.20M | -- | -- | -- |
| Total Debt Repaid | -192.60K | -127.10K | -61.60K | -30.80K | -- |
| Issuance of Common Stock | 40.46M | 56.72M | 72.98M | 86.92M | 100.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.31M | -3.74M | -4.18M | -4.97M | -5.76M |
| Cash from Financing | 41.44M | 43.16M | 45.25M | 53.84M | 62.47M |
| Foreign Exchange rate Adjustments | -36.70K | 110.40K | 256.00K | 157.50K | 57.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.92M | 4.88M | 19.75M | 32.44M | 45.42M |